sotalol has been researched along with Cardiomyopathies in 13 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We explored the central hemodynamic responses to oral sotalol during dose titration in patients with ventricular arrhythmias who underwent programmed ventricular stimulation." | 7.68 | Effect of oral sotalol on systemic hemodynamics and programmed electrical stimulation in patients with ventricular arrhythmias and structural heart disease. ( Deitchman, D; Gomes, JA; Kukin, M; Pe, E; Stewart, D; Winters, SL, 1993) |
| "Sotalol is a non-selective beta-adrenergic blocking agent with class III antiarrhythmic properties." | 5.27 | The effect of sotalol on exercise-induced ventricular arrhythmias. ( Glogar, D; Petzl, DH; Probst, P; Schuster, E, 1988) |
| "A case is described of cardiogenic shock that occurred following use of sotalol in a patient with severe left ventricular dysfunction." | 3.81 | Left Ventricular Assist Device (LVAD) as a Bridge to Recovery for Tachycardia-Mediated Cardiomyopathy. ( Bergin, P; Kaye, DM; Mariani, JA; McGiffin, DC; Saxena, P; Stokes, MB, 2015) |
| "We explored the central hemodynamic responses to oral sotalol during dose titration in patients with ventricular arrhythmias who underwent programmed ventricular stimulation." | 3.68 | Effect of oral sotalol on systemic hemodynamics and programmed electrical stimulation in patients with ventricular arrhythmias and structural heart disease. ( Deitchman, D; Gomes, JA; Kukin, M; Pe, E; Stewart, D; Winters, SL, 1993) |
| " At each dosing extreme, on-drug JTc was significantly longer in women (p < or =0." | 2.69 | JTc prolongation with d,l-sotalol in women versus men. ( Archibald, D; Hardy, S; Lehmann, MH; MacNeil, DJ, 1999) |
| "Sotalol is a non-selective beta-adrenergic blocking agent with class III antiarrhythmic properties." | 1.27 | The effect of sotalol on exercise-induced ventricular arrhythmias. ( Glogar, D; Petzl, DH; Probst, P; Schuster, E, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarangi, PK | 1 |
| Joseph, E | 1 |
| Irodi, A | 1 |
| Chacko, BR | 1 |
| Chase, D | 1 |
| Ge, H | 2 |
| Li, X | 2 |
| Zhang, Y | 1 |
| Liu, H | 2 |
| Jiang, H | 2 |
| Stokes, MB | 1 |
| Saxena, P | 1 |
| Mariani, JA | 1 |
| Kaye, DM | 1 |
| Bergin, P | 1 |
| McGiffin, DC | 1 |
| Winter, RL | 1 |
| Hariu, CD | 1 |
| Saunders, AB | 1 |
| Furushima, H | 1 |
| Chinushi, M | 2 |
| Okamura, K | 1 |
| Komura, S | 1 |
| Tanabe, Y | 1 |
| Sato, A | 1 |
| Izumi, D | 1 |
| Aizawa, Y | 2 |
| Winters, SL | 1 |
| Kukin, M | 1 |
| Pe, E | 1 |
| Stewart, D | 1 |
| Deitchman, D | 1 |
| Gomes, JA | 1 |
| Montero, M | 1 |
| Schmitt, C | 1 |
| Lehmann, MH | 1 |
| Hardy, S | 1 |
| Archibald, D | 1 |
| MacNeil, DJ | 1 |
| Laurenzi, F | 1 |
| Avella, A | 1 |
| Adinolfi, E | 1 |
| Dini, P | 1 |
| Mezaki, T | 1 |
| Aoki, Y | 1 |
| Nakagawa, I | 1 |
| Washizuka, T | 1 |
| Hackett, LP | 1 |
| Wojnar-Horton, RE | 1 |
| Dusci, LJ | 1 |
| Ilett, KF | 1 |
| Roberts, MJ | 1 |
| Petzl, DH | 1 |
| Probst, P | 1 |
| Glogar, D | 1 |
| Schuster, E | 1 |
2 trials available for sotalol and Cardiomyopathies
| Article | Year |
|---|---|
Effect of dl-sotalol on mortality and recurrence of ventricular tachyarrhythmias: ischemic compared to nonischemic cardiomyopathy.
Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Comorbidity; Female; Humans; Incidence; Japan; Male; | 2007 |
JTc prolongation with d,l-sotalol in women versus men.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Cardiomyopathies; Electrocardiography; Female; Humans; | 1999 |
11 other studies available for sotalol and Cardiomyopathies
| Article | Year |
|---|---|
An unusual childhood cardiomyopathy.
Topics: Adolescent; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Contrast Media; Diagnosis, | 2019 |
[Clinical course and treatment of ectopic atrial tachycardia in 144 children].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Child; Child, Preschool; Ec | 2015 |
Left Ventricular Assist Device (LVAD) as a Bridge to Recovery for Tachycardia-Mediated Cardiomyopathy.
Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Heart Ventricles; Heart-Assist Devices; Humans; Male; Midd | 2015 |
Predictors of Pharmacological Therapy of Ectopic Atrial Tachycardia in Children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Child; Child, Preschool; China; Drug Therapy, | 2017 |
ECG of the month. Arrhythmogenic right ventricular cardiomyopathy in a Boxer.
Topics: Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzazepines; Cardiomyopathies; Cardiotoni | 2010 |
Effect of oral sotalol on systemic hemodynamics and programmed electrical stimulation in patients with ventricular arrhythmias and structural heart disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiac Pacing, Artifici | 1993 |
Recording of transmembrane action potentials in chronic ischemic heart disease and dilated cardiomyopathy and the effects of the new class III antiarrhythmic agents D-sotalol and dofetilide.
Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Coronary Disease; Heart; Heart Ventricles; Humans; In Vitr | 1996 |
[Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopath | 1999 |
Demonstration of transient entrainment in monomorphic sustained ventricular tachycardia associated with cardiac sarcoidosis.
Topics: Cardiomyopathies; Electric Stimulation Therapy; Electrocardiography; Humans; Male; Middle Aged; Pred | 2000 |
Excretion of sotalol in breast milk.
Topics: Adult; Arrhythmias, Cardiac; Cardiomyopathies; Female; Humans; Infant, Newborn; Milk, Human; Pregnan | 1990 |
The effect of sotalol on exercise-induced ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiomyopathies; Coronary Disease; D | 1988 |